CareDx, Inc. (1K9)
XDUS
Closed
Oct 20, 2026
Day's Range
59.0052 wk Range
12.20Overview - 1K9 - CareDx, Inc.
Key Statistics
Valuation
Enterprise Value
-39.23M
P/E (Trailing)
‪-137.50‬
PEG Ratio
‪0.09‬
Price / Book
‪6.65‬
EV / EBITDA
‪-37.18‬
Profitability
Gross Margin
‪73.50%‬
Profit Margin
‪67.55%‬
Operating Margin
‪-6.60%‬
Return on Assets
‪-5.16%‬
Return on Equity
‪-7.04%‬
Ownership
Shares Outstanding
51.48M
Price stats
50-Day Avg
‪45.93‬
200-Day Avg
‪25.82‬
Peers - 1K9 - CareDx, Inc.
Peer Comparison
Compared with companies in Diagnostics & Research listed on XDUS.
- 1K9XDUSCareDx, Inc.+77.16%52-week change-137.50P/E (Trailing)‪67.55%‬Profit Margin
- NL0XDUSGRAIL, Inc.+53.52%52-week change-10.50P/E (Trailing)‪-236.94%‬Profit Margin
- 0MEXDUSTwist Bioscience Corporation+80.08%52-week change-108.42P/E (Trailing)‪50.72%‬Profit Margin
- ILUXDUSIllumina, Inc.+65.36%52-week change44.52P/E (Trailing)‪66.08%‬Profit Margin
- 5GHXDUSGuardant Health Inc.+64.22%52-week change-45.10P/E (Trailing)‪64.46%‬Profit Margin
- 1HMXDUSAdaptive Biotechnologies Corporation Common Stock+52.26%52-week change-64.18P/E (Trailing)‪74.23%‬Profit Margin
- 04XXDUSPersonalis Inc.+51.53%52-week change-15.62P/E (Trailing)‪22.65%‬Profit Margin
Profile Summary - 1K9 - CareDx, Inc.
About
CareDx, Inc. is a precision medicine diagnostics company focused on transplant care and related specialty services. CareDx develops and commercializes non-invasive molecular tests, laboratory products, digital tools, and patient support services that help clinicians monitor organ health before and after…
The information on this page is provided for general informational purposes only and is not investment advice.
Market data provided by Twelve Data. Charting by TradingView.
Last updated:
